135 related articles for article (PubMed ID: 8541527)
1. BB-10010: an active variant of human macrophage inflammatory protein-1 alpha with improved pharmaceutical properties.
Hunter MG; Bawden L; Brotherton D; Craig S; Cribbes S; Czaplewski LG; Dexter TM; Drummond AH; Gearing AH; Heyworth CM; Lord BI; McCourt M; Varley PG; Wood LM; Edwards RM; Lewis PJ
Blood; 1995 Dec; 86(12):4400-8. PubMed ID: 8541527
[TBL] [Abstract][Full Text] [Related]
2. Polymerization of murine macrophage inflammatory protein 1 alpha inactivates its myelosuppressive effects in vitro: the active form is a monomer.
Mantel C; Kim YJ; Cooper S; Kwon B; Broxmeyer HE
Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2232-6. PubMed ID: 8460127
[TBL] [Abstract][Full Text] [Related]
3. Macrophage-inflammatory protein protects multipotent hematopoietic cells from the cytotoxic effects of hydroxyurea in vivo.
Lord BI; Dexter TM; Clements JM; Hunter MA; Gearing AJ
Blood; 1992 May; 79(10):2605-9. PubMed ID: 1586712
[TBL] [Abstract][Full Text] [Related]
4. Biological and structural properties of MIP-1 alpha expressed in yeast.
Clements JM; Craig S; Gearing AJ; Hunter MG; Heyworth CM; Dexter TM; Lord BI
Cytokine; 1992 Jan; 4(1):76-82. PubMed ID: 1617159
[TBL] [Abstract][Full Text] [Related]
5. Mobilization of early hematopoietic progenitor cells with BB-10010: a genetically engineered variant of human macrophage inflammatory protein-1 alpha.
Lord BI; Woolford LB; Wood LM; Czaplewski LG; McCourt M; Hunter MG; Edwards RM
Blood; 1995 Jun; 85(12):3412-5. PubMed ID: 7540061
[TBL] [Abstract][Full Text] [Related]
6. Cloning and characterization of a novel murine macrophage inflammatory protein-1 alpha receptor.
Meyer A; Coyle AJ; Proudfoot AE; Wells TN; Power CA
J Biol Chem; 1996 Jun; 271(24):14445-51. PubMed ID: 8662890
[TBL] [Abstract][Full Text] [Related]
7. Uncoupling of stem cell inhibition from monocyte chemoattraction in MIP-1alpha by mutagenesis of the proteoglycan binding site.
Graham GJ; Wilkinson PC; Nibbs RJ; Lowe S; Kolset SO; Parker A; Freshney MG; Tsang ML; Pragnell IB
EMBO J; 1996 Dec; 15(23):6506-15. PubMed ID: 8978677
[TBL] [Abstract][Full Text] [Related]
8. Macrophage inflammatory protein-1 alpha mediated growth inhibition in a haemopoietic stem cell line is associated with inositol 1,4,5 triphosphate generation.
Heyworth CM; Pearson MA; Dexter TM; Wark G; Owen-Lynch PJ; Whetton AD
Growth Factors; 1995; 12(3):165-72. PubMed ID: 8619922
[TBL] [Abstract][Full Text] [Related]
9. Macrophage inflammatory protein-1 alpha receptors are present on cells enriched for CD34 expression from patients with chronic myeloid leukemia.
Chasty RC; Lucas GS; Owen-Lynch PJ; Pierce A; Whetton AD
Blood; 1995 Dec; 86(11):4270-7. PubMed ID: 7492787
[TBL] [Abstract][Full Text] [Related]
10. The tetrapeptide AcSDKP specifically blocks the cycling of primitive normal but not leukemic progenitors in long-term culture: evidence for an indirect mechanism.
Cashman JD; Eaves AC; Eaves CJ
Blood; 1994 Sep; 84(5):1534-42. PubMed ID: 8068944
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of acute myelogenous leukemia progenitor proliferation by macrophage inflammatory protein 1-alpha.
Ferrajoli A; Talpaz M; Zipf TF; Hirsch-Ginsberg C; Estey E; Wolpe SD; Estrov Z
Leukemia; 1994 May; 8(5):798-805. PubMed ID: 8182937
[TBL] [Abstract][Full Text] [Related]
12. A novel chemokine, macrophage inflammatory protein-related protein-2, inhibits colony formation of bone marrow myeloid progenitors.
Youn BS; Jang IK; Broxmeyer HE; Cooper S; Jenkins NA; Gilbert DJ; Copeland NG; Elick TA; Fraser MJ; Kwon BS
J Immunol; 1995 Sep; 155(5):2661-7. PubMed ID: 7650394
[TBL] [Abstract][Full Text] [Related]
13. Demonstration of stem cell inhibition and myeloprotective effects of SCI/rhMIP1 alpha in vivo.
Dunlop DJ; Wright EG; Lorimore S; Graham GJ; Holyoake T; Kerr DJ; Wolpe SD; Pragnell IB
Blood; 1992 May; 79(9):2221-5. PubMed ID: 1571537
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. Interacting effects involving suppression, synergistic suppression, and blocking of suppression.
Broxmeyer HE; Sherry B; Cooper S; Lu L; Maze R; Beckmann MP; Cerami A; Ralph P
J Immunol; 1993 Apr; 150(8 Pt 1):3448-58. PubMed ID: 7682242
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor beta: is it a downregulator of stem cell inhibition by macrophage inflammatory protein 1 alpha?
Maltman J; Pragnell IB; Graham GJ
J Exp Med; 1993 Sep; 178(3):925-32. PubMed ID: 8394405
[TBL] [Abstract][Full Text] [Related]
16. Continuous infusion of macrophage inflammatory protein MIP-1alpha enhances leucocyte recovery and haemopoietic progenitor cell mobilization after cyclophosphamide.
Marshall E; Woolford LB; Lord BI
Br J Cancer; 1997; 75(12):1715-20. PubMed ID: 9192972
[TBL] [Abstract][Full Text] [Related]
17. BB-10010/MIP-1 alpha in vivo maintains haemopoietic recovery following repeated cycles of sublethal irradiation.
Lord BI; Marshall E; Woolford LB; Hunter MG
Br J Cancer; 1996 Oct; 74(7):1017-22. PubMed ID: 8855968
[TBL] [Abstract][Full Text] [Related]
18. Myelosuppressive effects in vivo with very low dosages of monomeric recombinant murine macrophage inflammatory protein-1 alpha.
Cooper S; Mantel C; Broxmeyer HE
Exp Hematol; 1994 Feb; 22(2):186-93. PubMed ID: 8299739
[TBL] [Abstract][Full Text] [Related]
19. Distinct and overlapping direct effects of macrophage inflammatory protein-1 alpha and transforming growth factor beta on hematopoietic progenitor/stem cell growth.
Keller JR; Bartelmez SH; Sitnicka E; Ruscetti FW; Ortiz M; Gooya JM; Jacobsen SE
Blood; 1994 Oct; 84(7):2175-81. PubMed ID: 7919333
[TBL] [Abstract][Full Text] [Related]
20. Cloning and characterization of a novel murine beta chemokine receptor, D6. Comparison to three other related macrophage inflammatory protein-1alpha receptors, CCR-1, CCR-3, and CCR-5.
Nibbs RJ; Wylie SM; Pragnell IB; Graham GJ
J Biol Chem; 1997 May; 272(19):12495-504. PubMed ID: 9139699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
